Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study
scientific article published on 05 October 2018
Author/s
author: Gilles Salles, René-Olivier Casasnovas, Corinne Haioun, Pierre Feugier, Hervé Tilly, Eric Van Den Neste, Franck Morschhauser, Achiel Van Hoof, Steven Le Gouill, Krimo Bouabdallah, Roch Houot, Guillaume Cartron, Christophe Fruchart, Emmanuelle Nicolas-Virelizier, Philippe Ruminy, Marie Maerevoet
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.